Trial Profile
Clinical Trials Insight: 700039567
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2008
Price :
$35
*
At a glance
- Drugs Vaniprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Merck & Co
- 08 Dec 2008 New trial record.